NCT05576454 Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT05472324 Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma. Status COMPLETED Phase PHASE2
NCT05147155 Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor Initiation Status COMPLETED Phase N/A
NCT05018299 Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma Status RECRUITING Phase PHASE2
NCT05001529 Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients. Status UNKNOWN Phase PHASE4
NCT04980755 Adapting Body Reprogramming for Severe Asthma: a Feasibility Study Status COMPLETED Phase NA
NCT04714567 Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients Status UNKNOWN Phase N/A
NCT04648839 Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain. Status COMPLETED Phase N/A
NCT04612556 Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04520165 Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04463836 Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA) Status UNKNOWN Phase N/A
NCT04438408 National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype. Status UNKNOWN Phase N/A
NCT04334031 Deployment o the Multidisciplinary Prospective Cohort Imminent Status RECRUITING Phase NA
NCT04272463 ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab Status COMPLETED Phase N/A